To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.
- Cat. No.:76002-542
- No. of wells:96 Wells
Novel Cell-free Sclerostin/LRP Binding Assay Ideal for Primary Inhibitor Screens.
- High sensitivity chemiluminescent readout (signal-to-noise ratio of ≥10)
- Rapid protocol yields results in just 2.5 hours
- No cell lines or transfection reagents required
- Reproducible, high-throughput amenable assay (Z’-factor 0.871)
- Amenable for high-throughput screening applications
The LEADING LIGHT® Sclerostin Screening System is a 1 x 96 well plate assay based on Sclerostin–LRP interaction. This system contains engineered LRP5-alkaline phosphatase (ALP) and human Sclerostin immobilized in a multi-well plate. LRP5-alkaline phosphatase binds to Sclerostin coated on the bottom of the well and is detected by the activity of alkaline phosphatase remaining after a washing step. This system can be used for drug screening to identify small molecule compounds, antibodies, DNA aptamers and peptides capable of modulating sclerostin-LRP interaction.